House of Commons – Nov. 14, 2017

Elimination Strategy For Tackling Hepatitis C

Proposed Motion - 11 signatures

Content

That this House recognises hepatitis C is a leading cause of premature death from liver disease; acknowledges that the condition is curable in most cases; understands that there are inequalities in access to treatment and diagnosis for people in disadvantaged groups; notes that recent data has revealed that the UK is falling behind targets to meet its commitment to eliminating hepatitis C as a public health concern by 2030; further notes that the reduction in price of new HCV oral therapies puts the NHS in a position to work innovatively with industry to look at how it can find and treat more patients and faster; notes a recent article in the Lancet which states that domestic funding is unlikely to be able to deliver the results in the 13 years that remain till 2030; and calls on the NHS to bring forward the publication of an elimination strategy for the UK, which includes innovative, long-term activities with industry, stakeholders and community-based organisations across the health sector.

View source

Additional Metadata

Field Value
Uin With Amendment Suffix 534

Party Breakdown

Party Count
Labour 6
DUP 1
Conservative 1
Plaid Cymru 1
Independent 1
Scottish National Party 1

Signatures

Person Date Signed
Virendra Sharma 2017-11-14
Jim Shannon 2017-11-15
Bob Blackman 2017-11-15
Chris Stephens 2017-11-15
Keith Vaz 2017-11-16
Sylvia Hermon 2017-11-16
Jim Cunningham 2017-11-20
Mary Glindon 2017-11-27
George Howarth 2017-11-21
Marie Rimmer 2017-11-21
Liz Saville-Roberts 2017-11-21